Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0
|
作者：
Chris Skedgel
Daniel Rayson
Tallal Younis
机构：
[1] University of East Anglia,Norwich Medical School
[2] Capital Health,Atlantic Clinical Cancer Research Unit
[3] Capital Health,Department of Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [41] Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors
    Minisini, A
    Spazzapan, S
    Crivellari, D
    Aapro, M
    Biganzoli, L
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (02) : 125 - 131
  • [42] Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
    Pfeil, Alena M.
    Allcott, Kim
    Pettengell, Ruth
    von Minckwitz, Gunter
    Schwenkglenks, Matthias
    Szabo, Zsolt
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 525 - 545
  • [43] Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors
    Laali, Elahe
    Fazli, Jinous
    Sadighi, Sanambar
    Mohammadi, Mehdi
    Gholami, Kheirollah
    Jahangard-Rafsanjani, Zahra
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 428 - 433
  • [44] Use of antimicrobial agents and granulocyte colony stimulating factors for febrile neutropenia in cancer patients in a tertiary care hospital in India
    Roy, V
    Saxena, D.
    Agarwal, M.
    Bahadur, A. K.
    Mishra, B.
    INDIAN JOURNAL OF CANCER, 2010, 47 (04) : 430 - 436
  • [45] Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy—a representative sample survey in Germany
    Hartmut Link
    J. Nietsch
    M. Kerkmann
    P. Ortner
    Supportive Care in Cancer, 2016, 24 : 367 - 376
  • [46] Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design
    Henk, Henry J.
    Li, Xiaoyan
    Becker, Laura K.
    Xu, Hairong
    Gong, Qi
    Deeter, Robert G.
    Barron, Richard L.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (01) : 37 - 50
  • [47] Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
    Glaspy, John
    Bondarenko, Igor
    Burdaeva, Olga
    Chen, Jianmin
    Rutty, Dean
    Li, Renshu
    Wang, Shufang
    Hou, Qingsong
    Li, Simon
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [48] Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer
    Yu, Joanne L.
    Chan, Kelvin
    Kurin, Michael
    Pasetka, Mark
    Kiss, Alex
    Sridhar, Srikala S.
    Warner, Ellen
    BREAST JOURNAL, 2015, 21 (06) : 658 - 664
  • [49] Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
    John Glaspy
    Igor Bondarenko
    Olga Burdaeva
    Jianmin Chen
    Dean Rutty
    Renshu Li
    Shufang Wang
    Qingsong Hou
    Simon Li
    Supportive Care in Cancer, 2024, 32
  • [50] Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study
    Kwok, Carol C. H.
    Wong, W. H.
    Chan, Landon L.
    Wong, Sabrina P. Y.
    Wang, F.
    Wong, Martin C. S.
    Tse, Shelly L. A.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (06) : 438 - 446
12345